Form 8-K - Current report:
SEC Accession No. 0001213900-25-031754
Filing Date
2025-04-15
Accepted
2025-04-15 08:00:40
Documents
15
Period of Report
2025-04-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea023825101-8k_avalonglobe.htm   iXBRL 8-K 25665
2 PRESS RELEASE OF THE REGISTRANT ISSUED ON APRIL 15, 2025 ea023825101ex99-1_avalon.htm EX-99.1 13805
6 GRAPHIC image_001.jpg GRAPHIC 3034
  Complete submission text file 0001213900-25-031754.txt   222821

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE albt-20250415.xsd EX-101.SCH 3035
4 XBRL LABEL FILE albt-20250415_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE albt-20250415_pre.xml EX-101.PRE 22372
17 EXTRACTED XBRL INSTANCE DOCUMENT ea023825101-8k_avalonglobe_htm.xml XML 3686
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

EIN.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 25837606
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)